The most common causes of pancreatic exocrine insufficiency are cystic fibrosis and chronic pancreatitis resulting in two major problems: poor nutrition and considerable social embarrassment. Steatorrhoea is mainly a consequence of failure of digestion and aqueous solubilisation of lipid leading to its malabsorption.
The mainstay of treatment in pancreatic steatorrhoea has been replacement of endogenous pancreatic enzymes by supplements from hog pancreas (pancreatin -Paynes and Byrne). This has often proved unsatisfactory in the long term as many patients require 20 or 30 tablets per meal and still experience the nutritional and social consequences of steatorrhoea. As much as 30000 U lipase are needed with each meal to abolish steatorrhoea. 1 (Fig. 1) A range of normal values was obtained from normal animals pre-operatively (9.9-12.3 mmol/24 h) with a median value of 10-8 mmol/24 h. Faecal fat excretion in group B was significantly raised when compared with normal animals demonstrating considerable fat malabsorption (p<0-01). There was no significant difference observed between animals of group A and Table Weight STOOL VOLUME (Fig. 2 ) Figure 2 shows that the pancreatectomised dog without exocrine therapy has steatorrhoea, but fungal lipase and pancreatin are equally effective in reducing stool volume to normal.
Discussion
Considerable and significant weight loss associated with fat malabsorption was confirmed in pancreatectomised animals receiving no exocrine replacement therapy over a three week period. The institution of either conventional pancreatin treatment or of acid stable lipase prevented this weight loss at the dosages used in this study. The lipase dosage of 400 mg provided 4800 U lipase and represented 8% of the lipase activity of the conventional therapy taking into account that over 90% of orally ingested conventional preparations of lipase are inactivated in the acid medium of the stomach. With the daily dosages of pancreatin and acid stable lipase, a statistically significant reduction of total faecal fat excretion/day of between 42 and 60% occurred when comparison was made over a similar period of no treatment. Considerable variations in faecal fat excretion in individual animals were noted, although weight changes were not so obvious. One animal with a mean faecal fat excretion before pancreatectomy of 11 mmol/24 h had concentrations of 40 and 36 mmolI24 h on replacement regimens. This observation may be because of the variation in acid output from the stomach and variable contributions of gastric and small intestinal lipase in different animals. 10 This is probably a reflection of using a fixed dosage rather than tailoring the replacement therapy and the needs of the individual.
The most significant finding was the demonstration that a very small dose of acid stable lipase (400 mg) was as effective as pancreatin (10 g 
